Kensington, CA, United States of America

Dean R Artis

USPTO Granted Patents = 38 (Patent Applications = 25)

CIPO Patents = 3 (Patent Applications = 1)

EPO Patents = 5 (Patent Applications = 4)

Average Co-Inventor Count = 7.4

ph-index = 25

Forward Citations = 1,745(Granted Patents)

Company Filing History:

Elan Pharmaceuticals, Inc.

Imago Pharmaceuticals, Inc.

patents

where one patent can have more than one assignee

Years Active: 2002-2023

Loading Chart...

38 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 11814404 - Inhibitors of complement factors and uses thereof (2023-11-14),

2. 10426760 - Compounds and methods for kinase modulation, and indications therefor (2019-10-01),

3. 9844539 - Compounds and methods for kinase modulation, and indications therefor (2017-12-19),

4. 9493485 - Spirocyclic dihydro-thiazine and dihydro-oxazine BACE inhibitors, and compositions and uses thereof (2016-11-15),

5. 9469640 - Compounds and methods for kinase modulation, and indications therefor (2016-10-18),

6. 8722702 - Compounds modulating c-fms and/or c-kit activity and uses therefor (2014-05-13),

7. 8541418 - Inhibitors of polo-like kinase (2013-09-24),

8. 8470821 - PDE4B inhibitors and uses therefor (2013-06-25),

9. 8470818 - Compounds and methods for kinase modulation, and indications therefor (2013-06-25),

10. 8461169 - Compounds modulating c-fms and/or c-kit activity (2013-06-11),

11. 8445503 - Inhibitors of polo-like kinase (2013-05-21),

12. 8415469 - Compounds and methods for kinase modulation, and indications therefor (2013-04-09),

13. 8404700 - Compounds modulating c-fms and/or c-kit activity and uses therefor (2013-03-26),

14. 8367828 - PPAR active compounds (2013-02-05),

15. 8268858 - Compounds and methods for kinase modulation, and indications therefor (2012-09-18),

Title: Dean R Artis: Innovator and Inventor in Pharmaceutical Science

Introduction

Dean R Artis is a prominent inventor based in Kensington, CA, whose contributions to pharmaceutical innovation have resulted in a remarkable portfolio of 38 patents. His work primarily focuses on developing therapeutic compounds for various diseases, showcasing his commitment to improving healthcare outcomes.

Latest Patents

Among Dean's latest innovations are two significant patents:

1. **Inhibitors of complement factors and uses thereof** - This patent discloses compounds of formula I and II, along with their pharmaceutically acceptable salts. It details methods for treating neurodegenerative disorders, inflammatory diseases, autoimmune diseases, ophthalmic diseases, and metabolic disorders using the described compounds.

2. **Compounds and methods for kinase modulation, and indications therefor** - This patent focuses on compounds that are active on protein kinases. It outlines methods for utilizing these compounds to treat diseases and conditions associated with aberrant activity of protein kinases, highlighting the importance of this research in addressing complex medical challenges.

Career Highlights

Throughout his esteemed career, Dean R Artis has worked with renowned companies such as Plexxikon Inc. and Genentech, Inc. His experience in these organizations has been pivotal in advancing innovative solutions in the pharmaceutical field. His expansive knowledge and expertise have made him a key figure in developing therapeutics aimed at significant health issues.

Collaborations

Dean has collaborated with notable professionals in the industry, including Prabha N Ibrahim and Chao Zhang. These partnerships reflect the collaborative nature of scientific research and innovation, contributing to the advancement of medical treatments and understanding of various diseases.

Conclusion

Dean R Artis stands out as a leading inventor in the pharmaceutical industry, driven by his passion for innovation and commitment to improving patient care. His extensive patent portfolio and collaborative efforts underscore the vital role inventors play in advancing health sciences and creating solutions for pressing medical challenges.

This text is generated by artificial intelligence and may not be accurate.